CD276 and prostate cancer: B7-H3 (CD276), a member of the B7 immunoglobulin superfamily, is a type I transmembrane protein that is notably overexpressed in various solid tumors, including bladder cancer, prostate cancer, and melanoma, while exhibiting limited expression in normal tissues.